Society ❯Health Issues ❯Obesity

Drug Accessibility

Public Health Cost of Medications Public Health Policy

Senator Warren Urges FTC to Scrutinize Novo Holdings' $16.5B Catalent Acquisition

The proposed merger raises antitrust concerns over Novo Nordisk's potential control in the GLP-1 drug market.